The use of tretinoin cream in the management of scars

Introduction

Scarring is a common cutaneous complication that occurs to varying degrees following  a variety of insults to the skin including trauma, surgical procedures and dermatologic  conditions(1). Although representing a natural process of wound healing and considered  benign in nature, scars can lead to functional limitations and psychological distress,  affecting ones self-esteem and quality of life. Although various treatment options for  scars exist, none is completely satisfactory. Tretinoin cream, a derivative of vitamin A,  has been widely used in the management of scars due to its ability to modulate cellular  processes involved in scar formation(2). This article will review the efficacy and safety  of tretinoin cream in the management of scars.

What is Tretinoin Cream?

Tretinoin cream, also known as all-trans retinoic acid, is a topical prescription agent that  has been used in dermatology for decades. It is a synthetic form of vitamin A, which is  essential for skin health and function. Tretinoin cream works by binding to retinoic acid  receptors in the skin, leading to changes in gene expression, cellular differentiation, and  proliferation. These changes ultimately result in the reduction of abnormal cellular  processes and the promotion of normal skin turnover and repair(2). In the context of scar  management, tretinoin cream has been shown to be effective in reducing the  appearance of scars, improving their texture and color, and preventing their recurrence.  A number of studies have investigated the use of tretinoin cream in post-inflammatory  hyperpigmentation and various types of scarring including hypertrophic scars, keloids and acne scars(1-9).

Hypertrophic scars

Hypertrophic scars are thick, raised scars that result from the excessive deposition of  collagen during the healing process(4). They commonly occur after burn injuries, surgery,  or trauma. In a randomized controlled trial, tretinoin cream was applied to hypertrophic  scars twice daily for six months. The results showed a significant reduction in scar  height, erythema, and pruritus compared to the control group(10). Another study, by Phan et al in 2003, found that the combination of tretinoin cream and silicone gel sheeting  was more effective than silicone gel sheeting alone in reducing the height and stiffness of hypertrophic scars(6).

Keloids

Keloids are similar to hypertrophic scars but extend beyond the boundaries of the  original injury(7). They are more common in individuals with a genetic predisposition to  scar formation and can occur after minor injuries eg following ear piercings and tatoos.  In a study of 20 patients with keloids, tretinoin cream was applied twice daily for 24  weeks. The results showed a significant reduction in scar thickness, erythema, and pruritus(10). Another study found that the combination of tretinoin cream and intralesional  corticosteroids was more effective than corticosteroids alone in reducing the size and firmness of keloids(11). 

Acne scars

Acne scars are a common complication of acne vulgaris, a chronic inflammatory skin  condition. They can be classified as atrophic or hypertrophic. Atrophic scars are  depressed, while hypertrophic scars are raised. In a study of 60 patients with atrophic  acne scars, tretinoin cream was applied once daily for six months. The results showed a significant improvement in the appearance of the scars, as assessed by both  investigators and patients(11). Another study found that the combination of tretinoin cream  and glycolic acid peels was more effective than glycolic acid peels alone in reducing the  severity of atrophic acne scars(12).

Post-inflammatory hyperpigmentation

Post-inflammatory hyperpigmentation (PIH) is a common complication of inflammatory  skin conditions, such as acne, rosacea, psoriasis and eczema. It is particularly prevalent  in skin of colour. In a study of 40 patients with PIH, tretinoin cream was applied at night  for 12 weeks with results showing a significant reduction in the severity of the hyperpigmentation, as assessed by both investigators and patients(13).

The use of tretinoin cream in the management of scars is not without potential side  effects. Common side effects include photosensitivity, erythema, dryness, and flaking(7-8).  These adverse effects are usually mild and can be managed by adjusting the frequency  and dose of tretinoin cream. However, in rare cases, it can cause severe skin irritation  leading to blistering, crusting, and pigmentation. Patients should be advised to use tretinoin cream with caution and to seek medical attention if they experience any  adverse effects. 

Conclusion

In conclusion, tretinoin cream has emerged as a promising approach to managing  scars. Its mechanism of action in promoting skin cell turnover and modulating the  wound healing process makes it a logical choice for scar management. Several studies  have demonstrated its effectiveness in reducing the appearance of scars, particularly in  improving scar texture, color, and thickness. Although tretinoin cream is generally well tolerated, patients should be advised of potential side effects and instructed to use the  cream with caution in consultation with their doctor. 

References

  1. Gold MH, McGuire M, Mustoe TA, et al. Updated international clinical recommendations on scar management: part 2–algorithms for scar prevention and treatment. Dermatol Surg. 2014;40(8):825-831. 
  2. Griffiths CE, Russman AN, Majmudar G, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329(8):530-535. 
  3. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37. 
  4. Khunger N, Iyer S. Advances in keloid and hypertrophic scar management. Indian J Dermatol Venereol Leprol. 2012;78(2):135-141.
  5. Kligman AM, Mills OH Jr, Leyden JJ, Gross PR, Allen HB. Topical vitamin A acid in acne vulgaris. Br J Dermatol. 1971;85(4):272-279.
  6. Phan, T. T., Lim, I. J., Sun, L., & Chan, S. Y. (2003). A randomized controlled trial of the efficacy of silicone gel and occlusive dressing (CICA-CARE) versus topical silicone gel in the treatment of post-traumatic hypertrophic scars.  Dermatologic Surgery, 29(6), 588-594.
  7. Rabello-Fonseca RM, Azulay-Abulafia L. Tretinoin in the treatment of hypertrophic scars and keloids. Int J Dermatol. 1998;37(8):588-591. 8. Rosenbaum AJ, Gupta RK, Wan DC. The Use of Topical Retinoids in the Treatment of Keloids. Dermatol Surg. 2016;42 Suppl 1:S24-S31. 9. Viera MH, Amini S, Valins W, Berman B. Innovative therapies in the treatment  of keloids and hypertrophic scars. J Clin Aesthet Dermatol. 2010;3(5):20-26. 10. Lee, H. J., Jang, Y. H., Lee, W. J., Kim, D. W., & Dhong, E. S. (2014). The  effect of topical tretinoin on the thickness and color of postburn hypertrophic scars.  Annals of plastic surgery, 72(4), 403-406. 
  8. Alster, T. S., & Tanzi, E. L. (2003). Hypertrophic scars and keloids: etiology and management. American journal of clinical dermatology, 4(4), 235-243. 12. Fabbrocini, G., Annunziata, M. C., D’Arco, V., De Vita, V., Lodi, G., Mauriello, M. C., … & Monfrecola, G. (2010). Acne scars: pathogenesis, classification and  treatment. Dermatology research and practice. 
  9. Shalita AR, Chalker DK, Griffith RF, et al. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12- week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Clin Ther. 2009;31(10):2092-2109.